Yield10 Bioscience, Inc.

NasdaqCM:YTEN Stock Report

Market Cap: US$3.6m

Yield10 Bioscience Management

Management criteria checks 3/4

Yield10 Bioscience's CEO is Olly Peoples, appointed in Oct 2016, has a tenure of 7.58 years. total yearly compensation is $598.55K, comprised of 57.5% salary and 42.5% bonuses, including company stock and options. directly owns 0.48% of the company’s shares, worth $17.33K. The average tenure of the management team and the board of directors is 7.6 years and 7.7 years respectively.

Key information

Olly Peoples

Chief executive officer

US$598.6k

Total compensation

CEO salary percentage57.5%
CEO tenure7.6yrs
CEO ownership0.5%
Management average tenure7.6yrs
Board average tenure7.7yrs

Recent management updates

Recent updates

Yield10 Bioscience GAAP EPS of $0.70 beats by $1.39, revenue of $0.1M misses by $0.06M

Aug 10

Is Yield10 Bioscience (NASDAQ:YTEN) In A Good Position To Invest In Growth?

Nov 12
Is Yield10 Bioscience (NASDAQ:YTEN) In A Good Position To Invest In Growth?

Yield10 Bioscience (NASDAQ:YTEN) Is In A Good Position To Deliver On Growth Plans

Jul 19
Yield10 Bioscience (NASDAQ:YTEN) Is In A Good Position To Deliver On Growth Plans

Yield10 Bioscience, Inc.'s (NASDAQ:YTEN) CEO Will Probably Find It Hard To See A Huge Raise This Year

May 18
Yield10 Bioscience, Inc.'s (NASDAQ:YTEN) CEO Will Probably Find It Hard To See A Huge Raise This Year

Here's Why We're Watching Yield10 Bioscience's (NASDAQ:YTEN) Cash Burn Situation

Apr 14
Here's Why We're Watching Yield10 Bioscience's (NASDAQ:YTEN) Cash Burn Situation

Yield10 Bio secures $12.7M capital raise

Feb 01

Yield10 Bioscience under pressure on launching stock offering

Jan 29

When Will Yield10 Bioscience, Inc. (NASDAQ:YTEN) Become Profitable?

Jan 22
When Will Yield10 Bioscience, Inc. (NASDAQ:YTEN) Become Profitable?

We're Keeping An Eye On Yield10 Bioscience's (NASDAQ:YTEN) Cash Burn Rate

Nov 23
We're Keeping An Eye On Yield10 Bioscience's (NASDAQ:YTEN) Cash Burn Rate

Yield10 Bioscience, Inc. 2020 Q3 - Results - Earnings Call Presentation

Nov 13

CEO Compensation Analysis

How has Olly Peoples's remuneration changed compared to Yield10 Bioscience's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$599kUS$344k

-US$14m

Sep 30 2023n/an/a

-US$14m

Jun 30 2023n/an/a

-US$14m

Mar 31 2023n/an/a

-US$14m

Dec 31 2022US$527kUS$331k

-US$14m

Sep 30 2022n/an/a

-US$13m

Jun 30 2022n/an/a

-US$12m

Mar 31 2022n/an/a

-US$12m

Dec 31 2021US$2mUS$315k

-US$11m

Sep 30 2021n/an/a

-US$11m

Jun 30 2021n/an/a

-US$10m

Mar 31 2021n/an/a

-US$9m

Dec 31 2020US$1mUS$289k

-US$10m

Sep 30 2020n/an/a

-US$14m

Jun 30 2020n/an/a

-US$14m

Mar 31 2020n/an/a

-US$14m

Dec 31 2019US$600kUS$275k

-US$13m

Sep 30 2019n/an/a

-US$8m

Jun 30 2019n/an/a

-US$9m

Mar 31 2019n/an/a

-US$9m

Dec 31 2018US$738kUS$275k

-US$9m

Sep 30 2018n/an/a

-US$11m

Jun 30 2018n/an/a

-US$11m

Mar 31 2018n/an/a

-US$11m

Dec 31 2017US$382kUS$225k

-US$11m

Compensation vs Market: Olly's total compensation ($USD598.55K) is about average for companies of similar size in the US market ($USD663.90K).

Compensation vs Earnings: Olly's compensation has increased whilst the company is unprofitable.

CEO

Olly Peoples (65 yo)

7.6yrs

Tenure

US$598,554

Compensation

Dr. Oliver P. Peoples, also known as Olly, Ph D., is a Co-founder of Metabolix Inc., and has been its Chief Executive Officer and President since October 17, 2016. Dr. Peoples served as its Chief Scientifi...

Leadership Team

NamePositionTenureCompensationOwnership
Oliver Peoples
Co-Founder7.6yrsUS$598.55k0.48%
$ 17.3k
Kristi Snell
VP of Research & Chief Science Officer7.6yrsUS$406.26k0.27%
$ 9.6k
Lynne Brum
VP of Planning & Corporate Communications and Secretary7.6yrsUS$366.98k0.26%
$ 9.3k
Charles Haaser
VP of Finance9.5yrsUS$251.94k0.27%
$ 9.5k

7.6yrs

Average Tenure

62yo

Average Age

Experienced Management: YTEN's management team is seasoned and experienced (7.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Oliver Peoples
Co-Founder31.9yrsUS$598.55k0.48%
$ 17.3k
Richard Hamilton
Independent Director7.2yrsUS$74.84k0.47%
$ 17.0k
Robert Van Nostrand
Independent Chairman of the Board17.6yrsUS$84.84k0.32%
$ 11.4k
Anthony Sinskey
Independent Director31.9yrsUS$74.84k0.42%
$ 15.0k
Heike Sederoff
Member of Scientific Advisory Board7.7yrsno datano data
Danny Schnell
Member of Scientific Advisory Board8.3yrsno datano data
Jay Thelen
Member of Scientific Advisory Board5.8yrsno datano data
Sherri Brown
Independent Director4.3yrsUS$57.34k0%
$ 0
Willie Loh
Independent Director1.6yrsUS$57.34k0%
$ 0

7.7yrs

Average Tenure

65.5yo

Average Age

Experienced Board: YTEN's board of directors are considered experienced (7.7 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.